IMMUNISBIO Is a specialized company developing immunotherapy drugs based on NK cell manufacturing technology. IMMUNISBIO has secured independent technology throughout the entire process from development to production of immunotherapy drugs. We have commercialized NK cell therapy in several countries and are conducting clinical trials in Korea for patients with various cancers and autoimmune diseases. IMMUNISBIO is concentrating all its capabilities to become a leading company in the 21st-century advanced regenerative medicine and cell therapy fields, growing into a company that realizes the value of respect for life.

AutoBator® (Automatic production of cell therapy products).
AutoBator Using an integrated vision (image) module and AI image analysis algorithms, it reads the growth status, density, and clustering of cells in real time and automatically adjusts the optimal culture conditions.